Cognitive therapy for drug-resistant auditory hallucinations: A case example

A Casebook of Cognitive Therapy for Psychosis

Volumn , Issue , 2014, Pages 132-147

  Morrison, Anthony P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85076570696     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (32)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th edn). Washington, DC: APA.
2. Baker, C., & Morrison, A.P. (1998). Metacognition, intrusive thoughts, and auditory hallucinations. Psychological Medicine, 28, 1199-1208.
3. Beck, A.T. (1976). Cognitive therapy and the emotional disorders. New York: International Universities Press.
4. Bentall, R.P. (1990). The syndromes and symptoms of psychosis: Or why you can't play twenty questions with the concept of schizophrenia and hope to win. In R.P. Bentall (Ed.), Reconstructing schizophrenia (pp. 23-60). London: Routledge.
5. Bentall, R.P., Baker, G., & Havers, S. (1991). Reality-monitoring and psychotic hallucinations. British Journal of Clinical Psychology, 30, 213-222.
6. Bentall, R.P., & Slade, P.D. (1985). Reality-testing and auditory hallucinations: A signal detection analysis. British Journal of Clinical Psychology, 24, 159-169.
7. Chadwick, P., & Birchwood, M. (1994). The omnipotence of voices. A cognitive approach to auditory hallucinations. British Journal of Psychiatry, 164, 190-201.
8. Chadwick, P.D., & Birchwood, M. (1995). The omnipotence of voices II: The Beliefs About Voices Questionnaire (BAVQ). British Journal of Psychiatry, 166, 773-776.
9. Clark, D.M., & Wells, A. (1995). A cognitive model of social phobia. In R. Heimberg, M. Leibowitz, D.A. Hope, & F.R. Schneier (Eds.), Social phobia: Diagnosis, assessment, and treatment (pp. 69-93). New York: Guilford Press.
10. Drury, V., Birchwood, M., & Cochrane, R. (1996). Cognitive therapy and recovery from acute psychosis: A controlled trial I: Impact on psychotic symptoms. British Journal of Psychiatry, 169, 593-601.
11. Frith, C.D. (1979). Consciousness, information processing, and schizophrenia. British Journal of Psychiatry, 134, 225-235.
12. Garety, P.A., Kuipers, L., Fowler, D., Chamberlain, F., & Dunn, G. (1994). Cognitive behavioural therapy for drug-resistant psychosis. British Journal of Medical Psychology, 67, 259-271.
13. Gould, L.N. (1950). Verbal hallucinations as automatic speech. American Journal of Psychiatry, 107, 110-119.
14. Haddock, G., McCarron, J., Tarrier, N., & Faragher, E.B. (1999). Scales to measure dimensions of hallucinations and delusions: The psychotic symptom rating scales (PSYRATS). Psychological Medicine, 29, 879-889.
15. Haddock, G., Slade, P.D., Bentall, R.P., Reid, D., & Faragher, B.F. (1998). A comparison of the long-term effectiveness of distraction and focusing in the treatment of auditory hallucinations. British Journal of Medical Psychology, 71, 339-349.
16. Hansson, L., Bjorkman, T., & Svensson, B. (1995). The assessment of needs in psychiatric patients. Acta Psychiatrica Scandinavica, 92, 285-293.
17. Heilbrun, A.R. (1980). Impaired recognition of self-expressed thought in patients with auditory hallucinations. Journal of Abnormal Psychology, 89, 728-736.
18. Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
19. Kingdon, D.G., & Turkington, D. (1991). The use of cognitive behaviour therapy with a normalising rationale in schizophrenia. Journal of Nervous and Mental Disease, 179, 207-211.
20. Kingdon, D.G., & Turkington, D. (1993). Cognitive behavioural therapy of schizophrenia. New York: Guilford.
21. Kuipers, E., Fowler, D., Garety, P., Chisholm, D., Freeman, D., Dunn, G., Bebbington, P., & Hadley, C. (1998). London-East Anglia randomised controlled trial of cognitive behaviour therapy for psychosis III: Follow-up and economic evaluation at 18 months. British Journal of Psychiatry, 173, 61-68.
22. Kuipers, E., Garety, P., Fowler, D., Dunn, G., Bebbington, P., Freeman, D., & Hadley, C. (1997). The London-East Anglia randomised controlled trial of cognitive behavioural therapy for psychosis I: Effects of the treatment phase. British Journal of Psychiatry, 171, 319-327.
23. Margo, A., Hemsley, D.R., & Slade, P.D. (1981). The effects of varying auditory input on schizophrenic hallucinations. British Journal of Psychiatry, 139, 122-127.
24. Morrison, A.P. (1998). A cognitive analysis of auditory hallucinations: Are voices to schizophrenia what bodily sensations are to panic? Behavioural and Cognitive Psychotherapy, 26, 289-302.
25. Morrison, A.P., & Haddock, G. (1997a). Cognitive factors in source monitoring and auditory hallucinations. Psychological Medicine, 27, 669-679.
26. Morrison, A.P., & Haddock, G. (1997b). Self-focused attention in schizophrenic patients and normal subjects: A comparative study. Personality and Individual Differences, 23, 937-941.
27. Morrison, A.P., Haddock, G., & Tarrier, N. (1995). Intrusive thoughts and auditory hallucinations: A cognitive approach. Behavioural and Cognitive Psychotherapy, 23, 265-280.
28. Morrison, A.P., Wells, A., & Nothard, S. (2000). Cognitive factors in predisposition to auditory and visual hallucinations. British Journal of Clinical Psychology, 39, 67-78.
29. Slade, P.D., & Bentall, R.P. (1988). Sensory deception: A scientific analysis of hallucination. London: Croom Helm.
30. Tarrier, N. (1999). Specific effect of cognitive behaviour therapy for schizophrenia is not proved: Author's reply. British Medical Journal, 318, 331.
31. Tarrier, N., Beckett, R., Harwood, S., Baker, A., Yusupoff, L., & Ugarteburu, I. (1993). A trial of two cognitive behavioural methods of treating drug-resistant psychotic symptoms in schizophrenic patients: Outcome. British Journal of Psychiatry, 162, 524-532.
32. Tarrier, N., Yusupoff, L., Kinney, C., McCarthy, E., Gledhill, A., Haddock, G., & Morris, J. (1998). Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. British Medical Journal, 317, 303-307.